Cognitive restructuring compared with progressive muscle relaxation on comorbid depression and anxiety in chronic obsessive-compulsive disorder
Cognitive restructuring and OCD
DOI:
https://doi.org/10.22122/cdj.v11i2.392Keywords:
Cognitive Restructuring, Progressive Muscle Relaxation, Depression, Anxiety, Chronic, Obsessive-Compulsive DisorderAbstract
BACKGROUND: Comorbidities are one of the major factors in the failure of treatment of chronic obsessive-compulsive disorder (OCD). The present study examines the efficacy of cognitive restructuring (CR) and progressive muscle relaxation (PMR) on depression and anxiety in patients with chronic OCD.
METHODS: In this experimental study, from among 112 patients referred to a clinic for treatment of OCD in Tehran, Iran, in 2019, sixty people who were eligible were selected and assigned randomly into three groups: two experimental groups, CR and PMR, and a control group; each of them included twenty persons. After pre-test in all three groups, two experimental groups received CR and PMR interventions separately in group format. In the end, all groups completed Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI). Data were analyzed using covariance, Bonferroni adjusted alpha, and L-matrix in SPSS software.
RESULTS: Though CR and PMR both were effective in improving depression and anxiety in patients with OCD, CR was more effective in reduction of depression and PMR was more effective in reduction of anxiety (P = 0.001).
CONCLUSION: CR is effective for depression and obsessions and PMR is more effective in anxiety in patients with chronic OCD.
References
Abramowitz JS, Reuman L. Obsessive compulsive disorder. In: Zeigler-Hill V, Shackelford TK, editors. Encyclopedia of personality and individual differences. Cham, Switzerland: Springer International Publishing; 2020. p. 3304-6.
Hofmann SG, Wu JQ, Boettcher H. Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: a meta-analysis. J Consult Clin Psychol. 2014; 82(3): 375-91.
Law C, Boisseau CL. Exposure and response prevention in the treatment of obsessive-compulsive disorder: Current perspectives. Psychol Res Behav Manag. 2019; 12: 1167-74.
Sharma E, Tripathi A, Grover S, Avasthi A, Dan A, Srivastava C, et al. Clinical profile of obsessive-compulsive disorder in children and adolescents: A multicentric study from India. Indian J Psychiatry. 2019; 61(6): 564-71.
Arumugham SS, Reddy YC. Commonly asked questions in the treatment of obsessive-compulsive disorder. Expert Rev Neurother. 2014; 14(2): 151-63.
Del Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis DA, et al. Psychopharmacological treatment of obsessive-compulsive disorder (OCD). Curr Neuropharmacol. 2019; 17(8): 710-36.
Afzal MU. Obsessive compulsive disorder (OCD) recognition. A review. J Curr Res Sci. 2014; 2(6): 920-4.
Kyrios M, Ahern C, Fassnacht DB, Nedeljkovic M, Moulding R, Meyer D. Therapist-assisted internet-based cognitive behavioral therapy versus progressive relaxation in obsessive-compulsive disorder: Randomized controlled trial. J Med Internet Res. 2018; 20(8): e242.
Ost LGr, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014. Clin Psychol Rev. 2015; 40: 156-69.
Pascual-Vera B, Roncero M, Doron G, Belloch A. Assisting relapse prevention in OCD using a novel mobile app-based intervention: A case report. Bull Menninger Clin. 2018; 82(4): 390-406.
Manjula M, Sudhir PM. New-wave behavioral therapies in obsessive-compulsive disorder: Moving toward integrated behavioral therapies. Indian J Psychiatry. 2019; 61(Suppl 1): S104-S113.
Hellberg SN, Buchholz JL, Twohig MP, Abramowitz JS. Not just thinking, but believing: Obsessive beliefs and domains of cognitive fusion in the prediction of OCD symptom dimensions. Clin Psychol Psychother. 2020; 27(1): 69-78.
Nayebaghayee A, Aleyasin SA, Heidari H, Davodi H. Effectiveness of metacognitive therapy on dysfunctional beliefs, inflated sense of responsibility, and intolerance of uncertainty in patients with obsessive-compulsive disorder (OCD). Clinical Psychology Studies. 2019; 9(33): 1-24.
McKay D, Sookman D, Neziroglu F, Wilhelm S, Stein DJ, Kyrios M, et al. Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder. Psychiatry Res. 2015; 225(3): 236-46.
Twohig MP, Hayes SC, Plumb JC, Pruitt LD, Collins AB, Hazlett-Stevens H, et al. A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. J Consult Clin Psychol. 2010; 78(5): 705-16.
Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996; 67(3): 588-97.
Hossein KH, Mousavi AS. Psychometric properties of the Persian version of Beck Anxiety Inventory (BAI). Tehran Univ Med J. 2008; 66(2): 136-40.
Khesht-Masjedi MF, Omar Z, Masoleh SMK. Psychometrics properties of the Persian version of Beck Anxiety Inventory in North of Iranian adolescents. Int J Educ Psychol Res. 2015; 1(2): 145-53.
Kaviani H, Mousavi A S. Psychometric properties of the Persian version of Beck Anxiety Inventory (BAI). Tehran Univ Med J. 2008; 66 (2) :136-40
Jacobson, E. Progressive relaxation: A physiological and clinical investigation of muscular states and their significance in psychology and medical practice. 1st ed. Chicago, IL: University of Chicago Press; 1938.
Mohyadini H, Bakhtiar Pour S, Pasha R, Ehteshmzadeh P. Effectiveness of cognitive-behavioral treatment community on progress in patients with obsessive-compulsive disorders. Women Health Bull. 2021; 8(1): 18-25.
Hezel DM, Simpson HB. Exposure and response prevention for obsessive -compulsive disorder: A review and new directions. Indian J Psychiatry. 2019; 61(Suppl 1): S85 -92.
Olatunji BO, Davis ML, Powers MB, Smits JA. Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res. 2013; 47(1): 33-41.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chronic Diseases Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
